Pam Taub, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Novo Nordisk Inc.(MODEST), amarin(MODEST), Esperion(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Epirium Bio(NONE) RESEARCH/RESEARCH GRANTS: Amgen Inc.(SIGNIFICANT)

View Full Disclosure